Knowledge and attitudes of incoming pharmacy students toward pharmacogenomics and survey reliability
Abstract
Aims: To assess knowledge and attitudes toward pharmacogenomics (PGx) of incoming doctoral pharmacy students, to evaluate the internal structure and reliability of the PGx survey and to identify variables associated with the different responses. Methods: A PGx survey based on the core pharmacist competencies in PGx was created. Results: Of 83.2% analyzable responses, 91% believed PGx is a useful tool and relevant to future practice but over 70% stated they lack confidence in clinical PGx knowledge. This 38-item PGx survey included three factors showing high reliability. Prior genetic/PGx testing and unsatisfactory medication experiences were associated with a more positive attitude toward PGx. Conclusion: The majority of students have positive attitudes toward PGx, but lack knowledge in genetic concepts and clinical PGx.
Tweetable abstract
A pharmacogenomics (PGx) survey with high reliability showed that incoming doctoral pharmacy students have positive attitudes toward PGx, but lack knowledge of genetic concepts and clinical PGx.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. Pharmacogenomics. Lancet 394(10197), 521–532 (2019).
- 2. Pharmacogenomics education, research and clinical implementation in the state of Minnesota. Pharmacogenomics 22(11), 681–691 (2021).
- 3. Precision pharmacotherapy: integrating pharmacogenomics into clinical pharmacy practice. J. Am. Coll. Clin. Pharm. 2(3), 303–313 (2019).
- 4. Strategic vision for improving human health at The Forefront of Genomics. Nature 586(7831), 683–692 (2020).
- 5. . ASHP statement on the pharmacist's role in clinical pharmacogenomics. Am. J. Health Syst. Pharm. 79(8), 704–707 (2021).
- 6. Assessment of the pharmacogenomics educational needs of pharmacists. Am. J. Pharm. Educ. 75(3), 51 (2011).
- 7. . Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists. J. Am. Pharm. Assoc. 54(5), 510–517 (2003).
- 8. . A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations. Pharmacogenomics 18(3), 215–225 (2017).
- 9. . Pharmacogenetics and pharmacogenomics instruction in colleges and schools of pharmacy in the United States. Am. J. Pharm. Ed. 69(2), (2005). www.ajpe.org/content/74/1/7/tab-article-info
- 10. . Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am. J. Pharm. Educ. 74(1), 7 (2010).
- 11. . Pharmacogenomics courses in pharmacy school curricula. Pharmacogenomics 20(9), 625–630 (2019). •• The most recent review of curricula-related pharmacogenomics courses in 132 US pharmacy schools.
- 12. . Aligning the AACP strategic engagement agenda with key federal priorities in health: Report of the 2016–17 Argus Commission. Am. J. Pharm. Educ. 81(8), S15 (2017).
- 13. National Center for Biotechnology Information. Core Competencies in Genetics Essential for All Healthcare Professionals (Third Edition) (2015). www.ncbi.nlm.nih.gov/books/NBK115543/
- 14. . American Pharmacists A. Integrating pharmacogenomics into pharmacy practice via medication therapy management. J. Am. Pharm. Assoc. 51(6), e64–e74 (2011).
- 15. Accreditation Council for Pharmacy Education. Accreditation Standards and Key Elements for the Professional Program in Pharmacy Leading to the Doctor of Pharmacy Degree (Standards 2016) (2015). www.acpe-accredit.org/pdf/Standards2016FINAL2022.pdf
- 16. Pharmacists leading the way to precision medicine: updates to the core pharmacist competencies in genomics. Am. J. Pharm. Educ. 86(4), 8634 (2021). •• A key article on the core pharmacist competencies in genomics outlined by the 2021 American Association of Colleges of Pharmacy Pharmacogenomics Special Interest Group.
- 17. . Knowledge, attitude, and perceptions of pharmacists and pharmacy students towards pharmacogenomics in Zimbabwe. Pharmacy (Basel) 5(3), 36 (2017).
- 18. Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine. Hum. Genomics 12(1), 50 (2018).
- 19. . Pharmacogenomics education improves pharmacy student perceptions of their abilities and roles in its use. Am. J. Pharm. Educ. 82(9), 6424 (2018). • This research paper demonstrated that a required first-year course on Principles in Genetics and Pharmacogenomics had positive impact on students' knowledge and role in the application of pharmacogenomics.
- 20. . Knowledge and attitudes of pharmacy students towards pharmacogenomics among universities in Jordan and West Bank of Palestine. Pharmacogenomics Pers. Med. 12, 247–255 (2019). • A survey assessing how a required first-year course on pharmacogenomics impacts perceptions of pharmacogenomics among second- to fourth-year pharmacy students.
- 21. Pharmacy students' attitudes and perceptions toward pharmacogenomics education. Am. J. Health Syst. Pharm. 76(11), 836–845 (2019). • A survey of attitudes and perceptions toward pharmacogenomics among first-year pharmacy students in eight pharmacy schools/colleges in New York and New Jersey.
- 22. Attitudes and awareness toward pharmacogenomics and personalized medicine adoption among health sciences trainees: experience from Greece and lessons for Europe. OMICS 25(3), 190–199 (2021).
- 23. . What do students in pharmacy and medicine think about pharmacogenomics and personalized medicine education? Awareness, attitudes, and perceptions in Malaysian Health Sciences. OMICS 25(1), 52–59 (2021). • A survey on the attitudes and perceptions toward pharmacogenomics and personalized medicine education among pharmacy and medical students in Malaysia.
- 24. Efficacy of personal pharmacogenomic testing as an educational tool in the pharmacy curriculum: a nonblinded, randomized controlled trial. Clin. Transl. Sci. 14(6), 2532–2543 (2021). •• A recent nonblinded, randomized controlled trial assessing how personal genomic educational testing may impact student knowledge and attitudes related to pharmacogenomics.
- 25. . Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J. Med. Internet Res. 6(3), e34 (2004).
- 26. . On test and measures of group divergence: theoretical formulae. Journal and Proceedings of Asiatic Society of Bengal (New Series) 26, 541–588 (1930).
- 27. . Repairing Tom Swift's electric factor analysis machine. Underst. Stat. 2(1), 13–43 (2003).
- 28. . Efficient theory development and factor retention criteria: a bandon the ‘eigenvalue greater than one’ criterion. J. Bus. Res. 61(2), 162–170 (2008).
- 29. .Multivariate Data Analysis (7th Edition). Pearson Education, Harlow,United Kingdom, (2014).
- 30. . The sources of four commonly reported cutoff criteria–what did they really say? Organ Res. Methods 9(2), 202–220 (2006).
- 31. R Core Team. R: Alanguage and environment for statistical computing. R Foundation for Statistical Computing (2022). www.R-project.org/
- 32. . psych: Procedures for Psychological, Psychometric, and Personality Research [Software] (2022). https://CRAN.R-project.org/package=psych
- 33. . {lavaan}: An {R} package for structural equation modeling. J. Stat. Softw. 48(2), 1–36 (2012).
- 34. Knowledge and attitude regarding pharmacogenetics among formerly pregnant women in the Netherlands and their interest in pharmacogenetic research. BMC Pregnancy Childbirth 17, 120 (2017).
- 35. . Patient experiences with pharmacogenetic testing in a primary care setting. Pharmacogenomics 17(15), 1629–1636 (2016).
- 36. . Clinical application and educational training for pharmacogenomics. Pharmacy (Basel) 8(3), 163 (2020).
- 37. . A review of exploratory factor analysis decisions and overview of current practices: what we are doing and how can we improve? Int. J. Hum-Comput. Int. 32(1), 51–62 (2016). • Current practices and suggestions for exploratory factor analysis.